News
Diagnostic test Xpert MTB/RIF proven fast and effective in low-resource settings
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test…
EAC Health Ministers sixth annual meeting in the Republic of Burundi: participation in EDCTP programme encouraged
The Ministers of Health of the East African Community, Permanent Secretaries and Senior government officials responsible for policies on health, research and regulatory issues convened…
World Tuberculosis Day 2011: EDCTP contributes to fill research gaps
The European and Developing Countries Clinical Trials Partnership (EDCTP) fully supports the ambition of the international Stop TB Partnership to transform the fight for the…
International Women’s Day 2011: EDCTP hails the contribution of women to its clinical trial projects
The European and Developing Countries Clinical Trials Partnership (EDCTP) celebrates the 100th International Women’s Day by honouring the contribution of women, in all capacities in…
G-FINDER 2010 shows change of focus on R&D funding
The third annual G-FINDER survey, the most comprehensive report to date on public and private funding into research and development (R&D) for neglected diseases, was…
TB drug candidate SQ109 in the top five most promising Q1 drugs entering phase II trials
Thomson Reuters reports on most promising drugs changing clinical phase in the first quarter of 2011. The SQ109, a novel anti-TB drug candidate that could…
AMANET announces good progress of the Phase 2 Clinical Trial of Candidate Malaria Vaccine GMZ2 in Gabon
The African Malaria Network Trust (AMANET) and the consortium investigating the efficacy of malaria vaccine candidate GMZ2 proudly announce the good progress of the GMZ2…
Kesho Bora study results offer new hope for mother-to-child transmission of HIV during breastfeeding
A new study published in Lancet Infectious Diseases of 14 January 2011 shows that giving a triple antiretroviral therapy (ART) during pregnancy, delivery and breastfeeding…
World AIDS Day - 1 December 2010: EDCTP joins forces in the fight against HIV/AIDS
Every year on 1 December, the world comes together in solidarity to raise awareness about HIV. On the 22nd World AIDS Day, the European and…
Trials begin on potential vaccine to prevent mother-to-child transmission of HIV after birth
The Medical Research Council (MRC) together with researchers from Kenya, The Gambia, United States of America, Sweden, and Spain, has opened enrolment in two infant…
AMANET launches a Phase 2 Clinical Trial of Candidate Malaria Vaccine GMZ2
The African Malaria Network Trust (AMANET), through a grant received from the European and Developing Countries Clinical Trials Partnership (EDCTP), has launched a multi-site phase…
Sida and Swedish Ministry for Foreign Affairs launch shared database for researchers and research managers
Swedish International Development Cooperation Agency (Sida) and the Swedish Ministry for Foreign Affairs have developed a shared database called Researchers for Development Analysis (REDA). The…
Sequella Receives International Support for Phase 2 Clinical Trials of SQ109, its Lead Antitubercular Drug Candidate
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University…
First announcement: Sixth EDCTP Forum (9-12 October 2011): Strengthening Research Partnerships for Better Health and Sustainable Development
The Sixth EDCTP Forum will be held from 9 to 12 October 2011 in Addis Ababa, Ethiopia. The theme of the Forum isStrengthening Research Partnerships…
EU Member States meets to propose a second phase of EDCTP
The Federal Science Policy Office (BELSPO/STIS), in collaboration with the European Commission and EDCTP, is organising a meeting under the Belgian EU Presidency which aims…